TrialAlimentary pharmacology & therapeutics2025

Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials.

Edo J Dongelmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.